TWiPO #97: GD2-CAR T Cell Therapy for H3K27M-mutated Diffuse Midline Gliomas with Dr. Robbie Majzner - a podcast by Solving Kids Cancer

from 2022-07-15T10:13:22

:: ::

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/5TYFsjh91Tw


Listen in as our host, Dr. Brenda Weigel from the University of Minnesota, is joined by Dr. Robbie Majzner - an Assistant Professor of Pediatrics in the Division of Hematology and Oncology at Stanford University's School of Medicine. Dr. Majzner goes into great detail about his recent clinical trial on GD2-CAR T cell therapy for H3K27M-mutated Diffuse Midline Gliomas - the findings, the process, and what the future holds. You can read more about Dr. Majzner's study here: https://www.nature.com/articles/s41586-022-04489-4


Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org.


Subscribe to TWIPO to get notifications of new uploads.


Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast

Further episodes of This Week in Pediatric Oncology

Further podcasts by Solving Kids' Cancer

Website of Solving Kids' Cancer